Published in Neurobiol Aging on December 21, 2013
A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol (2015) 2.16
Alzheimer's disease genetics: from the bench to the clinic. Neuron (2014) 1.65
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Sci Transl Med (2016) 1.44
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet (2014) 1.17
CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci (2015) 1.04
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol (2016) 1.03
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci (2016) 0.97
Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways. Mol Cell Neurosci (2015) 0.94
The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders. J Alzheimers Dis Parkinsonism (2014) 0.81
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease. J Neurosci (2017) 0.80
Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European-Americans. Alzheimers Res Ther (2015) 0.80
Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities. Expert Rev Mol Diagn (2015) 0.79
Additional mechanisms conferring genetic susceptibility to Alzheimer's disease. Front Cell Neurosci (2015) 0.79
Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease. Am J Hum Genet (2016) 0.78
Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging (2016) 0.77
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology. Acta Neuropathol (2017) 0.75
A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression. Alzheimers Dement (2016) 0.75
Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice. PLoS One (2017) 0.75
Aβ and Inflammatory Stimulus Activate Diverse Signaling Pathways in Monocytic Cells: Implications in Retaining Phagocytosis in Aβ-Laden Environment. Front Cell Neurosci (2016) 0.75
Novel susceptibility loci for Alzheimer's disease. Future Neurol (2015) 0.75
Increased tauopathy drives microglia-mediated clearance of beta-amyloid. Acta Neuropathol Commun (2016) 0.75
A loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers. BMC Genomics (2016) 0.75
TREM2 in Neurodegenerative Diseases. Mol Neurodegener (2017) 0.75
Microglial Interferon Signaling and White Matter. Neurochem Res (2017) 0.75
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Population structure and eigenanalysis. PLoS Genet (2006) 37.21
On estimating the relation between blood group and disease. Ann Hum Genet (1955) 26.39
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol (2006) 11.23
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet (2008) 3.65
Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology (2003) 2.93
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell (2008) 2.55
TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol (2009) 2.44
TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Neurobiol Aging (2013) 2.19
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet (2010) 1.58
Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis. PLoS One (2011) 1.51
TREM2 and neurodegenerative disease. N Engl J Med (2013) 1.49
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum Mol Genet (2012) 1.43
Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Arch Neurol (2011) 1.34
Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS One (2011) 1.19
TREM2 and neurodegenerative disease. N Engl J Med (2013) 1.15
TREM2 and neurodegenerative disease. N Engl J Med (2013) 1.12
Cortical atrophy and language network reorganization associated with a novel progranulin mutation. Cereb Cortex (2008) 1.06
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res (2009) 3.31
Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology (2003) 2.93
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature (2013) 2.79
Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol (2010) 2.76
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci (2014) 2.36
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05
Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin (2013) 1.49
Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology (2013) 1.32
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels. J Alzheimers Dis (2010) 1.24
Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11
Hierarchical anatomical brain networks for MCI prediction: revisiting volumetric measures. PLoS One (2011) 1.09
LCC-Demons: a robust and accurate symmetric diffeomorphic registration algorithm. Neuroimage (2013) 1.05
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects. Neuroimage Clin (2013) 1.02
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet (2016) 1.02
APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimers Dement (2015) 0.91
Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur J Clin Nutr (2005) 0.91
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Hum Mol Genet (2014) 0.90
Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology (2015) 0.89
Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease. Neurobiol Aging (2014) 0.89
Diffusion weighted imaging-based maximum density path analysis and classification of Alzheimer's disease. Neurobiol Aging (2014) 0.89
Discrimination of AD and normal subjects from MRI: anatomical versus statistical regions. Neurosci Lett (2010) 0.88
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab (2016) 0.88
Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. Neuroimage Clin (2012) 0.88
Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage (2011) 0.87
Mapping ventricular expansion onto cortical gray matter in older adults. Neurobiol Aging (2014) 0.87
Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches. BMC Bioinformatics (2016) 0.84
Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging (2014) 0.83
Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimers Dement (2015) 0.83
Bridging the gap between statistical and biological epistasis in Alzheimer's disease. Biomed Res Int (2015) 0.82
Genetic variation at the CELF1 (CUGBP, elav-like family member 1 gene) locus is genome-wide associated with Alzheimer's disease and obesity. Am J Med Genet B Neuropsychiatr Genet (2014) 0.81
Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics. Drugs Aging (2010) 0.80
Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics. Mol Psychiatry (2013) 0.80
Manifold population modeling as a neuro-imaging biomarker: application to ADNI and ADNI-GO. Neuroimage (2014) 0.80
Connectivity network measures predict volumetric atrophy in mild cognitive impairment. Neurobiol Aging (2014) 0.80
Boosting brain connectome classification accuracy in Alzheimer's disease using higher-order singular value decomposition. Front Neurosci (2015) 0.79
Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure. Neurobiol Aging (2014) 0.79
CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease. Neuropsychopharmacology (2015) 0.79
Regional flux analysis for discovering and quantifying anatomical changes: An application to the brain morphometry in Alzheimer's disease. Neuroimage (2015) 0.79
Frontobasal gray matter loss is associated with the TREM2 p.R47H variant. Neurobiol Aging (2014) 0.79
Brain connectivity and novel network measures for Alzheimer's disease classification. Neurobiol Aging (2014) 0.79
White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease. J Alzheimers Dis (2015) 0.79
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. Acta Neuropathol (2017) 0.79
Apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging. Neurobiol Aging (2013) 0.77
Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement (2017) 0.76
Gene interactions and structural brain change in early-onset Alzheimer's disease subjects using the pipeline environment. Psychiatry Investig (2015) 0.76
Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease. J Alzheimers Dis (2015) 0.76
The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment. Hum Brain Mapp (2017) 0.75
Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion. Alzheimers Dement (2014) 0.75
Multivariate statistical analysis of diffusion imaging parameters using partial least squares: Application to white matter variations in Alzheimer's disease. Neuroimage (2016) 0.75
CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN. Exp Gerontol (2017) 0.75
A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin. Neurobiol Aging (2015) 0.75
Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease. Neurology (2017) 0.75
Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease. Alzheimers Dement (2016) 0.75
Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Med Phys (2009) 0.75
Cognitive reserve moderates the association between functional network anti-correlations and memory in MCI. Neurobiol Aging (2016) 0.75
Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2017) 0.75
Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry. J Alzheimers Dis (2017) 0.75
Exploring multifractal-based features for mild Alzheimer's disease classification. Magn Reson Med (2015) 0.75
Two distinct classes of degenerative change are independently linked to clinical progression in mild cognitive impairment. Neurobiol Aging (2017) 0.75
NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases. Neurobiol Aging (2017) 0.75
Improved Diagnostic Accuracy of Alzheimer's Disease by Combining Regional Cortical Thickness and Default Mode Network Functional Connectivity: Validated in the Alzheimer's Disease Neuroimaging Initiative Set. Korean J Radiol (2017) 0.75
Female-specific effect of the BDNF gene on Alzheimer's disease. Neurobiol Aging (2017) 0.75